Kernicterus: Clinical Trials

10 trials for Kernicterus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 4 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 21Active not recruiting 1
Phase 31Completed 1

Follow Kernicterus: new trials by email Literature Review of Kernicterus trials Research Report on Kernicterus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns
Skin color assessment - Neonatal Jaundice
Not yet recruitingAssistance Publique - Hôpitaux de Paris5102026-03-012026-01-02
Bilistick Point-of-care System 2.0 Bilirubin Validation
Bilistick System 2.0 point-of-care testing device - Neonatal Screening, Kernicterus
CompletedKettering Health Network802024-02-012025-03-13
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
usual prescribed intralipid (UL) regimen, restricted prescribed intralipid (RL) regimen - Bilirubin Encephalopathy
Phase 2Active not recruitingThe University of Texas Health Science Center, Houston1342021-02-112025-11-28
Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill
Baby treadmill, Physical rehabilitation training - Hypoxic-Ischemic Encephalopathy, Periventricular Leukomalacia
Not applicableWithdrawnChildren's Hospital of Fudan University2020-12-012023-12-29
Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill
Baby treadmill, Conventional physical rehabilitation training - Hypoxic-Ischemic Encephalopathy, Periventricular Leukomalacia
Not applicableTerminatedChildren's Hospital of Fudan University202020-12-012023-12-29
Complications of Exchange Transfusion in Neonates
blood group,complete blood count - Kernicterus
Not applicableUnknownAssiut University502018-04-152017-06-22
Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
Bilirubin Binding Capacity, End-tidal Carbon Monoxide, Carboxyhemoglobin - Bilirubin-induced Neurologic Dysfunction, Hyperbilirubinemia
CompletedStanford University1432016-02-012021-10-01
Does Maternal Instruction Prevent Kernicterus in Nigeria?
maternal education - Kernicterus
Not applicableCompletedBilimetrix s.r.l.17652014-01-012016-03-18
Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries
Hyperbilirubinemic Encephalopathy
CompletedUniversity of Minnesota6242012-12-012019-01-25
Efficacy and Safety of Stannsoporfin in Neonates
stannsoporfin, Sham Injection - Nutritional and Metabolic Diseases
Phase 3CompletedInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company1852002-05-012019-10-29

Narrower conditions

Hyperbilirubinemia (3)  ·  Jaundice, Neonatal (3)  ·  Cerebral Infarction (2)  ·  Hypoglycemia (2)  ·  Hypoxia-Ischemia, Brain (2)  ·  Leukomalacia, Periventricular (2)  ·  Premature Birth (2)  ·  Nutritional and Metabolic Diseases (1)

Broader conditions

Brain Diseases (10)  ·  Brain Diseases, Metabolic (10)  ·  Central Nervous System Diseases (10)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10)  ·  Erythroblastosis, Fetal (10)  ·  Hematologic Diseases (10)  ·  Hemic and Lymphatic Diseases (10)  ·  Immune System Diseases (10)  ·  Infant, Newborn, Diseases (10)  ·  Metabolic Diseases (10)  ·  Nervous System Diseases (10)  ·  Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Nutritional and Metabolic Diseases (9)  ·  Hyperbilirubinemia (7)

Interventions

Blood Cell Count (1)  ·  Blood Grouping and Crossmatching (1)  ·  Clinical Protocols (1)  ·  Educational Status (1)  ·  salicylhydroxamic acid (1)  ·  tin mesoporphyrin (1)

Sponsors

Children's Hospital of Fudan University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Bilimetrix s.r.l. (1)  ·  InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (1)  ·  Kettering Health Network (1)  ·  Stanford University (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Minnesota (1)

Countries

United States (4)  ·  China (2)  ·  France (1)  ·  Nigeria (1)

Top investigators

Abieyuwa Emokpae, MBBS (1)  ·  Angela Okolo, MBBS (1)  ·  Hanaa Ab Mohamed, Professor (1)  ·  Isa Abdulkadir, MBBS (1)  ·  Jonathan D Toot, MD (1)  ·  Lindsay F Holzapfel, MD, MS (1)  ·  Stephen Oguche, MBBS (1)  ·  Tina Slusher, MD (1)  ·  Vinod K Bhutani, MD (1)  ·  Zubaida Farouk, MBBS (1)

Results publications

PMID 15275978, PMID 17606558, PMID 19177057, PMID 20116355, PMID 24012586, PMID 24136687, PMID 25123212, PMID 25644966, PMID 25782975, PMID 26828941, PMID 36945475, PMID 42401326

NIH funding

KL2TR003168 (1)